1. Home
  2. OFIX vs AVXL Comparison

OFIX vs AVXL Comparison

Compare OFIX & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OFIX
  • AVXL
  • Stock Information
  • Founded
  • OFIX 1987
  • AVXL 2004
  • Country
  • OFIX United States
  • AVXL United States
  • Employees
  • OFIX N/A
  • AVXL N/A
  • Industry
  • OFIX Medical/Dental Instruments
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • OFIX Health Care
  • AVXL Health Care
  • Exchange
  • OFIX Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • OFIX 648.7M
  • AVXL 761.3M
  • IPO Year
  • OFIX N/A
  • AVXL N/A
  • Fundamental
  • Price
  • OFIX $12.11
  • AVXL $8.25
  • Analyst Decision
  • OFIX Strong Buy
  • AVXL Strong Buy
  • Analyst Count
  • OFIX 3
  • AVXL 2
  • Target Price
  • OFIX $23.33
  • AVXL $44.00
  • AVG Volume (30 Days)
  • OFIX 350.2K
  • AVXL 657.5K
  • Earning Date
  • OFIX 05-06-2025
  • AVXL 05-13-2025
  • Dividend Yield
  • OFIX N/A
  • AVXL N/A
  • EPS Growth
  • OFIX N/A
  • AVXL N/A
  • EPS
  • OFIX N/A
  • AVXL N/A
  • Revenue
  • OFIX $804,529,000.00
  • AVXL N/A
  • Revenue This Year
  • OFIX $4.87
  • AVXL N/A
  • Revenue Next Year
  • OFIX $6.40
  • AVXL N/A
  • P/E Ratio
  • OFIX N/A
  • AVXL N/A
  • Revenue Growth
  • OFIX 5.85
  • AVXL N/A
  • 52 Week Low
  • OFIX $12.08
  • AVXL $3.51
  • 52 Week High
  • OFIX $20.73
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • OFIX 30.25
  • AVXL 40.05
  • Support Level
  • OFIX $11.85
  • AVXL $8.20
  • Resistance Level
  • OFIX $14.26
  • AVXL $8.81
  • Average True Range (ATR)
  • OFIX 0.65
  • AVXL 0.41
  • MACD
  • OFIX -0.07
  • AVXL -0.12
  • Stochastic Oscillator
  • OFIX 40.86
  • AVXL 3.13

About OFIX Orthofix Medical Inc. (DE)

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

Share on Social Networks: